Condensed Consolidating Financial Information - Condensed Consolidating Cash Flow Statement (Details) - USD ($) $ in Millions | 9 Months Ended |
Sep. 30, 2015 | Sep. 30, 2014 |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | $ 176.4 | $ 184.5 |
Capital expenditures | (43) | (43.6) |
Acquisitions | (11.1) | 0 |
Net proceeds from dispositions | 8.8 | 2.3 |
Net cash flow provided by (used for) investing activities | (45.3) | (41.3) |
Proceeds from IPO | 0 | 615 |
Proceeds from long-term debt borrowings - term loan and senior notes | 0 | 1,598 |
Proceeds from long-term debt borrowings - new senior notes | 103.8 | 0 |
Proceeds from borrowings under revolving credit facility | 105 | 0 |
Repayments of borrowings under revolving credit facility | (105) | 0 |
Deferred financing costs | (3.3) | (24.8) |
Proceeds from stock option exercises | 2 | 0 |
Taxes withheld for stock-based compensation | (4) | 0 |
Distribution of debt and IPO proceeds to CBS | 0 | (2,038.8) |
Net cash contribution from CBS | 0 | 39.8 |
Dividends | (148.7) | (88.8) |
Intercompany | 0 | 0 |
Other | (0.6) | 0 |
Net cash flow provided by (used for) financing activities | (50.8) | 100.4 |
Effect of exchange rate changes on cash and cash equivalents | (2.4) | (1.2) |
Net increase in cash and cash equivalents | 77.9 | 242.4 |
Cash and cash equivalents at beginning of period | 28.5 | 29.8 |
Cash and cash equivalents at end of period | 106.4 | 272.2 |
Parent Company | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | (1.1) | (0.9) |
Capital expenditures | 0 | 0 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0 |
Net cash flow provided by (used for) investing activities | 0 | 0 |
Proceeds from IPO | | 615 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 2 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of debt and IPO proceeds to CBS | | (515) |
Net cash contribution from CBS | | 0 |
Dividends | (148.7) | (88.8) |
Intercompany | 147.8 | (10.3) |
Other | 0 | |
Net cash flow provided by (used for) financing activities | 1.1 | 0.9 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Subsidiary Issuer | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | (72) | (25.6) |
Capital expenditures | 0 | 0 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0 |
Net cash flow provided by (used for) investing activities | 0 | 0 |
Proceeds from IPO | | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 1,598 |
Proceeds from long-term debt borrowings - new senior notes | 103.8 | |
Proceeds from borrowings under revolving credit facility | 105 | |
Repayments of borrowings under revolving credit facility | (105) | |
Deferred financing costs | (3.3) | (24.8) |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of debt and IPO proceeds to CBS | | (1,523.8) |
Net cash contribution from CBS | | 0 |
Dividends | 0 | 0 |
Intercompany | 13.6 | 206.2 |
Other | 0 | |
Net cash flow provided by (used for) financing activities | 114.1 | 255.6 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 42.1 | 230 |
Cash and cash equivalents at beginning of period | 11.5 | 0 |
Cash and cash equivalents at end of period | 53.6 | 230 |
Guarantor Subsidiaries | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | 230.9 | 213.9 |
Capital expenditures | (39.6) | (37.4) |
Acquisitions | (11.1) | |
Net proceeds from dispositions | 8.8 | 2.1 |
Net cash flow provided by (used for) investing activities | (41.9) | (35.3) |
Proceeds from IPO | | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | (4) | |
Distribution of debt and IPO proceeds to CBS | | 0 |
Net cash contribution from CBS | | 39.8 |
Dividends | 0 | 0 |
Intercompany | (161.7) | (197) |
Other | (0.6) | |
Net cash flow provided by (used for) financing activities | (166.3) | (157.2) |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 22.7 | 21.4 |
Cash and cash equivalents at beginning of period | 8.8 | 2.1 |
Cash and cash equivalents at end of period | 31.5 | 23.5 |
Non-Guarantor Subsidiaries | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | 18.6 | (2.9) |
Capital expenditures | (3.4) | (6.2) |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0.2 |
Net cash flow provided by (used for) investing activities | (3.4) | (6) |
Proceeds from IPO | | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of debt and IPO proceeds to CBS | | 0 |
Net cash contribution from CBS | | 0 |
Dividends | 0 | 0 |
Intercompany | 0.3 | 1.1 |
Other | 0 | |
Net cash flow provided by (used for) financing activities | 0.3 | 1.1 |
Effect of exchange rate changes on cash and cash equivalents | (2.4) | (1.2) |
Net increase in cash and cash equivalents | 13.1 | (9) |
Cash and cash equivalents at beginning of period | 8.2 | 27.7 |
Cash and cash equivalents at end of period | 21.3 | 18.7 |
Eliminations | | |
Condensed Cash Flow Statements, Captions [Line Items] | | |
Net cash flow provided by (used for) operating activities | 0 | 0 |
Capital expenditures | 0 | 0 |
Acquisitions | 0 | |
Net proceeds from dispositions | 0 | 0 |
Net cash flow provided by (used for) investing activities | 0 | 0 |
Proceeds from IPO | | 0 |
Proceeds from long-term debt borrowings - term loan and senior notes | | 0 |
Proceeds from long-term debt borrowings - new senior notes | 0 | |
Proceeds from borrowings under revolving credit facility | 0 | |
Repayments of borrowings under revolving credit facility | 0 | |
Deferred financing costs | 0 | 0 |
Proceeds from stock option exercises | 0 | |
Taxes withheld for stock-based compensation | 0 | |
Distribution of debt and IPO proceeds to CBS | | 0 |
Net cash contribution from CBS | | 0 |
Dividends | 0 | 0 |
Intercompany | 0 | 0 |
Other | 0 | |
Net cash flow provided by (used for) financing activities | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | $ 0 | $ 0 |